Back to search

Article

Initial serum CA-125 and HE4 levels as predictors for optimal surgical cytoreduction in patients with stage III epithelial ovarian cancer

2022-09-30

Abstract excerpt

<h4>Background: </h4> Ovarian cancer (OC) lacks specific symptoms and screening methods, and most patients are diagnosed at an advanced stage with worse prognosis. Currently, the major treatment approaches for advanced epithelial ovarian carcinoma (AEOC) have been primary debulking surgery (PDS) followed by platinum-based chemotherapy, and neoadjuvant chemotherapy (NACT) followed by interval debulking surgery (IDS...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
646d5955-c43f-5ac0-83c4-e969e6ad46a6
DOI
10.21203/rs.3.rs-2108512/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Initial serum CA-125 and HE4 levels as predictors for optimal surgical cytoreduction in patients with stage III epithelial ovarian cancerDOI 10.21203/rs.3.rs-2108512/v1
Select a neighboring publication to make it the new centre.